fbpx

Inhalerx Ltd

IRX.AX

$0.03

Closing

▼-4.76%

1D

▲37.93%

YTD

IRX

BBG00FBDZ7Y4

Exchange

Sector

Market cap

$5.43M

Volume

246

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$5.43M

Analysts' Rating

-

Price Target (Mean)

0.00

Total Analysts

0

P/E

Operating Margin

-545.64%

Beta

-1.02

Revenue Growth

-71.55%

52 week high

$0.03

52 week low

$0.01

Div. Yield

%

EPS Growth

0.00

Company Profile

Inhalerx Limited is an Australia-based healthcare company. The Company is focused on developing medicinal drug-device products to address unmet medical needs in the pain management and mental health sectors. The Company partners with educators in their technical and therapeutic fields, to provide inhalation therapies that deliver added value for patients, doctors, business partners, governments, and stakeholders alike. Its Medihale Inhaler is a sealed pod inhaler designed specifically for use with inhaled formulations. It utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material. The sealed tamper-proof Medihale Pods provide patients with additional security. The Medihale Protective Charging Case automatically recharges the Medihale Inhaler when the inhaler is returned to its case. The Medihale Protective Charging Case even has a dedicated storage space to carry an extra Medihale c-liquid Pod.